Report
Martial Descoutures ...
  • Oussema Denguir

Sanofi : Une nouvelle pierre dans le développement d’un vaccin COVID-19

>Un nouvel accord avec un acteur des ARNm - Sanofi vient d’annoncer entrer dans une nouvelle collaboration avec la biotech Translate Bio. Cet accord a pour but de développer un nouveau candidat vaccin à ARNm contre COVID-19. Ce nouvel accord fait ainsi suite à la première collaboration entre les deux acteurs en 2018 qui portaient sur cinq agents pathogènes infectieux ainsi qu’une option sur d’autres agents pathogènes. L’ensemble de la transaction initiale était d...
Underlying
Sanofi

Sanofi is an integrated, global healthcare company focused on patient needs and engaged in the research, development, manufacture and marketing of healthcare products. Two segments make up Co.'s business: Pharmaceuticals and Vaccines. The Pharmaceuticals segment covers research, development, production and marketing of medicines, consisting of flagship products, plus a broad range of prescription medicines, generic medicines, and consumer health products. The Vaccines segment includes research, development, production and marketing of vaccines in five areas: pediatric vaccines, influenza vaccines, adult and adolescent booster vaccines, meningitis vaccines, and travel and endemic vaccines.

Provider
Oddo BHF
Oddo BHF

​Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.

Analysts
Martial Descoutures

Oussema Denguir

Other Reports on these Companies
Other Reports from Oddo BHF

ResearchPool Subscriptions

Get the most out of your insights

Get in touch